Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Read also

Ventus and Genentech

Ventus and Genentech partner for small-molecule medicine discovery

Aspire Pharma’s

Acquisition strengthens Aspire Pharma’s strategic portfolio

Alkermes to acquire Avadel for $2.1bn

Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn.

NanoViricides

NanoViricides reports antiviral activity of NV-387 against measles in preclinical studies